Nyxoah SA NYXH-BE:Euronext Brussels

RT Quote | Exchange | EUR
Last | 5:35 PM CEST
9.64quote price arrow up+1.06 (+12.35%)
Volume
148,547
52 week range
3.79 - 17.60
Loading...
  • Open9.16
  • Day High11.40
  • Day Low9.14
  • Prev Close8.58
  • 52 Week High17.60
  • 52 Week High Date03/19/24
  • 52 Week Low3.79
  • 52 Week Low Date01/19/24

Key Stats

  • Market Cap251.52M
  • Shares Out28.67M
  • 10 Day Average Volume40,974.3
  • Dividend-
  • Dividend Yield-
  • Beta0.5
  • YTD % Change126.29

KEY STATS

  • Open9.16
  • Day High11.40
  • Day Low9.14
  • Prev Close8.58
  • 52 Week High17.60
  • 52 Week High Date03/19/24
  • 52 Week Low3.79
  • 52 Week Low Date01/19/24
  • Market Cap251.52M
  • Shares Out28.67M
  • 10 Day Average Volume40,974.3
  • Dividend-
  • Dividend Yield-
  • Beta0.5
  • YTD % Change126.29

RATIOS/PROFITABILITY

  • EPS (TTM)-1.55
  • P/E (TTM)-6.21
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Nyxoah SA

 

Profile

MORE
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.
Robert Taub
Non-Executive Chairman of the Board
Olivier Taelman
Chief Executive Officer, Executive Director
Address
Rue Edouard Belin 12
Mont-saint-guibert
1435
Belgium